Holdings of Privium Fund Management B.V.
44 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 70.5 % of the equity sleeve
Sector breakdown
- Consumer discretionary 30.5 %
- Technology 15.7 %
- Industrials 6.1 %
- Health care 5.7 %
- Financials 3.9 %
- Consumer staples 3.2 %
- Unattributed 34.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 97.7 %
- BR 0.8 %
- KY 0.7 %
- DE 0.7 %
- GB 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 40 | 347.9M $ | 97.71 % |
| 2 | BR | 1 | 2.8M $ | 0.78 % |
| 3 | KY | 1 | 2.5M $ | 0.70 % |
| 4 | DE | 1 | 2.4M $ | 0.67 % |
| 5 | GB | 1 | 501.5K $ | 0.14 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Tesla Inc | 222,000 | 82.5M $ | |
| 2 | Palantir Technologies Inc | 200,000 | 29.3M $ | |
| 3 | Amazon.com Inc | 125,000 | 26M $ | |
| 4 | Arrowhead Pharmaceuticals Inc | 366,936 | 23M $ | |
| 5 | Ionis Pharmaceuticals Inc | 290,024 | 21.8M $ | |
| 6 | Lemonade Inc | 255,259 | 16M $ | |
| 7 | NVIDIA Corp | 81,000 | 14.1M $ | |
| 8 | Coinbase Global Inc | 79,000 | 13.8M $ | |
| 9 | Advanced Micro Devices Inc | 62,000 | 12.6M $ | |
| 10 | AST SpaceMobile Inc | 145,000 | 12M $ | |
| 11 | Sea Ltd | 138,000 | 11.4M $ | |
| 12 | Axsome Therapeutics Inc | 58,729 | 9.9M $ | |
| 13 | Esperion Therapeutics Inc | 3,299,441 | 9M $ | |
| 14 | Biogen Inc | 43,800 | 8M $ | |
| 15 | Ultragenyx Pharmaceutical Inc | 364,802 | 7.6M $ | |
| 16 | Arcutis Biotherapeutics Inc | 320,972 | 7.6M $ | |
| 17 | BioMarin Pharmaceutical Inc | 92,305 | 5.2M $ | |
| 18 | Vertex Pharmaceuticals Inc | 11,355 | 5.1M $ | |
| 19 | Denali Therapeutics Inc | 254,857 | 4.9M $ | |
| 20 | Alnylam Pharmaceuticals Inc | 12,222 | 4M $ | |
| 21 | Viridian Therapeutics Inc | 173,516 | 3.4M $ | |
| 22 | Krystal Biotech Inc | 11,170 | 2.9M $ | |
| 23 | Ambev SA | 948,558 | 2.8M $ | |
| 24 | ZAI LAB LTD | 132,189 | 2.5M $ | |
| 25 | BioNTech SE | 27,000 | 2.4M $ | |
| 26 | Stoke Therapeutics Inc | 50,000 | 1.6M $ | |
| 27 | 4D Molecular Therapeutics Inc | 170,256 | 1.6M $ | |
| 28 | Beam Therapeutics Inc | 63,982 | 1.5M $ | |
| 29 | Moderna Inc | 29,994 | 1.5M $ | |
| 30 | Pfizer Inc | 52,679 | 1.5M $ | |
| 31 | Lexeo Therapeutics Inc | 205,000 | 1.2M $ | |
| 32 | Cartesian Therapeutics Inc | 179,114 | 1.1M $ | |
| 33 | Molina Healthcare Inc | 8,140 | 1.1M $ | |
| 34 | Sarepta Therapeutics Inc | 46,000 | 1M $ | |
| 35 | Rocket Pharmaceuticals Inc | 242,146 | 866.9K $ | |
| 36 | Hims & Hers Health Inc | 40,000 | 830.4K $ | |
| 37 | Taysha Gene Therapies Inc | 181,900 | 813.1K $ | |
| 38 | NOV Inc | 42,026 | 790.5K $ | |
| 39 | SandRidge Energy Inc | 38,792 | 632.7K $ | |
| 40 | Autolus Therapeutics PLC | 363,430 | 501.5K $ | |
| 41 | Fate Therapeutics Inc | 414,311 | 497.2K $ | |
| 42 | Voyager Therapeutics Inc | 120,000 | 463.2K $ | |
| 43 | Tidewater Inc | 5,483 | 458.1K $ | |
| 44 | Sprott Funds Trust | 3,302 | 208.5K $ | |